Haw Par Corporation Limited

S$12.60As of Sun 8 Nov 2026, 12:00 UTC
SGX:H02Healthcare
Country Singapore
PE (Fwd) •••
TSR 10Y CAGR 7.80%
Div yield 3.17%
ROE 5.19%
Drug Manufacturers (General)
Beta (5Y) 0.10
PE TTM 12.17
TSR TTM (12.77%)
Mkt cap S$2.789B
ROIC 1.50%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$16
27.04%
(63.26%)
Hold 7|10|12|4|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.18
0.18
0.18
0.20
13.34%
8.58%
1.78%
9.88%
Revenue$M
114.5
119.5
117.3
117.8
0.20%
0.86%
1.87%
1.75%
Peers (US$2.175B)
Cap (US$)
PE
820.5M
15.61x
1.885B
9.072x
Capital
TTM
5Y
10Y
Leveragex
0.962
0.029
0.025
EBIT/Intx
1.076
0.062
0.060
Own earn%
(209.57)
135.04
130.41
Sh yield%
53.53
37.60
39.86
Owners
Insiders/Inst%
10.10
42.85
Short interest%
1.06
SBC / revenue%
5.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
9–18
$1 testx
—
Incr. ROIC%
32